Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients
Conditions: SLE; Lupus Nephritis; SGLT2 Inhibitors Interventions: Drug: dapagliflozin; Drug: placebo Sponsor: Mansoura University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Dapagliflozin | Forxiga | Heart | Lupus | Nephritis | Research | SGLT2 Inhibitors